Market Ends Lower as Sensex and Nifty Decline; Jubilant Pharma Gains, Persistent Systems Slips

April 03, 2025 09:23 PM AEDT | By Team Kalkine Media

Google News:

Market Ends Lower as Sensex and Nifty Decline; Jubilant Pharma Gains, Persistent Systems Slips — Image source: shutterstock

Recent News

Fed Daly eyes fall for possible policy shift

Fifth Third Announces Three-Year, $20M Investment in North Nashville

Inogen Alliance Associate Awards: Environment Analyst Sustainability D...

New Zealand Construction Report 2025: Output to Contract by 1% Due to...

Highlights:

The Sensex declined, closing lower at the end of the session.

The Nifty index moved below a key level during trading.

Jubilant Pharma's stock increased, while Persistent Systems' stock declined.

The Indian stock market experienced a decline in the latest trading session, with major indices closing in the red. The Sensex recorded a drop, while the Nifty index slipped below an important threshold. Investors monitored global and domestic factors influencing market sentiment throughout the session.

Sectoral Performance

The pharmaceutical sector displayed mixed results. Jubilant Pharma registered gains, standing out despite the overall market weakness. On the other hand, the technology sector witnessed a decline, with Persistent Systems seeing a notable drop in its stock price.

Broader Market Indicators

Market breadth showed a divergence between advancing and declining stocks. While major indices ended lower, several individual stocks recorded gains. Sectors such as banking and energy exhibited fluctuations, with some stocks maintaining stability despite the downturn.

Global Influences

International developments had an impact on domestic market performance. Reports of tariff measures introduced by a major global economy affected investor sentiment. Currency movements and commodity prices also played a role in shaping the day's trading patterns.

Investor Sentiment

Despite the decline in key indices, market participation remained active. The movement of mid-cap and small-cap stocks reflected varied sentiment across different sectors. Market participants continued to assess domestic and global cues for further direction.

Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (Kalkine Media, we or us), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.